logo

For the Inventor, By the Inventor

Frankfurt am Main, Germany

Gerhard Beck

USPTO Granted Patents = 47

Average Co-Inventor Count = 3.9

ph-index = 10

Forward Citations = 215(Granted Patents)


Company Filing History:

goldMedal45 out of 6,662 
 
Hoechst Aktiengesellschaft
 patents
silverMedal1 out of 1 
 
Hoechst Aktiengesellachaft
 patent
bronzeMedal1 out of 1,829 
 
Sanofi-a Ventis Deutschland Gmbh
 patents

Years Active: 1976-2006

Loading Chart...
Areas of Expertise:
Chiral Separation
Enantiomer Synthesis
Prostaglandin Derivatives
Pharmaceutical Compositions
Optically Active Compounds
Thromboxane Inhibitors
Stereoselective Synthesis
Pyrrolidone Derivatives
Leukotriene Antagonists
Cyclopentane Derivatives
Imidazolyl Compounds
Flavone Derivatives
47 patents (USPTO):Explore Patents
1. 7084250 - Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides (2006-08-01),
2. 6294562 - Salts of ethyl 3-(2-(4-(4-amino-imino-methyl)phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl)acetylamino)-3-phenylpropionate (2001-09-25),
3. 6018053 - Process for the preparation of chiral, nonracemic (2000-01-25),
4. 5861304 - Process for the enzymatic separation of enantiomers of (1999-01-19),
5. 5684185 - Process for the stereoselective synthesis of 3-substituted (1997-11-04),
6. 5554788 - Process for the stereoselective synthesis of 3-substituted (1996-09-10),
7. 5399722 - Process for preparing tert-butyl (1995-03-21),
8. 5294724 - 4-hydroxytetrahydropyran-2-ones and the corresponding (1994-03-15),
9. 5204351 - 6-fluoro-3,5-dihydroxy carboxylic acids and derivatives thereof (1993-04-20),
10. 5173498 - Substituted 3-thia- and 3-oxa-alkylflavones, a process for their (1992-12-22),
11. 5166171 - 6-phenoxymethyl-4-hydroxytetrahydropyran-2-ones and (1992-11-24),
12. 5055484 - 7(1H-pyrrol-3-YL)-substituted 3,5-dihydroxyhept-6-enoic acids, (1991-10-08),
13. 4977279 - Process for the preparation of optically active 3-demethylmevalonic acid (1990-12-11),
14. 4970313 - Optically active 3-demethylmevalonic acid derivatives, and intermediates (1990-11-13),
15. 4946852 - 4(R)-substituted 6(S)-phenoxymethyl-, 6(S)-.beta.-phenylethyl- and (1990-08-07),

Title: Gerhard Beck: A Pioneer in Pharmaceutical Innovations

Introduction

Gerhard Beck is a prolific inventor based in Frankfurt am Main, Germany. With an impressive portfolio of 47 patents, he has made significant contributions to the field of pharmaceuticals, particularly in the area of blood coagulation factor inhibitors.

Latest Patents

Among his latest innovations, Beck has developed a process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides. This invention focuses on effective inhibitors of the blood coagulation factor Xa, which can be vital in preventing thrombosis. The process involves sophisticated chemical reactions, such as asymmetric hydrogenation, indicating Beck's advanced understanding of organic chemistry. Additionally, he has also patented ethyl 3-(2-(4-(4-amino-imino-methyl)phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl)acetylamino)-3-phenylpropionate salts, showcasing his commitment to developing new therapeutic agents.

Career Highlights

Beck's career is marked by his tenure at notable organizations such as Hoechst Aktiengesellschaft and Hoechst Aktiengesellschaft. His work at these companies allowed him to leverage his expertise in pharmaceutical innovation, driving forward significant advancements in drug development.

Collaborations

Throughout his career, Beck has collaborated with esteemed colleagues like Wilhelm Bartmann and Gunther Wess. These partnerships have been instrumental in the successful execution of various innovative projects, further enhancing the impact of his work in the field.

Conclusion

Gerhard Beck's contributions to pharmaceutical innovations are evident in his numerous patents and successful collaborations. His work on blood coagulation inhibitors has the potential to significantly improve patient care and therapeutic outcomes in the medical field. As an inventor, Beck continues to inspire those in the industry with his commitment to advancing health solutions through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…